glp-1 drugs news Weight loss and addiction: Study shows may help reduce overdose risks GLP-1 Receptor Agonist Shortage: Challenges

LEAD-4 Study Investigators

( / mice on high-fat diet

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials

Possible mechanisms for their beneficial effects in individuals with NAFLD are: (i) reduction of visceral adipose tissue and thus IR

A Phase III, Multi-Center, Randomized, Double-Blind and Placebo-Controlled Study to Evaluate the Efficacy and Safety of XW003 in Adults With Overweight or Obesity (SLIMMER)

The final strategy emphasizes L-cell differentiation, with the goal of increasing the number of GLP-1-producing L-cells in the intestine